|1.||Pichichero, Michael E: 2 articles (03/2007 - 03/2007)|
|2.||Ji, Qing: 1 article (01/2015)|
|3.||Sui, Hua: 1 article (01/2015)|
|4.||Liu, Xuan: 1 article (01/2015)|
|5.||Li, Fu-Feng: 1 article (01/2015)|
|6.||Liu, Yan-Na: 1 article (01/2015)|
|7.||Li, Qi: 1 article (01/2015)|
|8.||Zhou, Li-Hong: 1 article (01/2015)|
|9.||Sun, Zhu-Mei: 1 article (01/2015)|
|10.||Yokozawa, Takako: 1 article (07/2013)|
06/25/1966 - "Because of the apparent absence of dose-related toxic effects in humans, cephaloridine was particularly useful in the treatment of patients with renal disease and infections due to susceptible bacteria."
10/01/1977 - "Preoperative administration of cephaloridine reduced this high rate of infection to 5% in a prospective randomized but not blinded trial. "
10/01/1970 - "Further studies of the use of cephaloridine in the control of infection in the newborn."
08/01/1966 - "Laboratory and clinical studies of a new antibiotic, cephaloridine, in the treatment of gram-positive infections."
01/01/1980 - "The difference in infection rates for 'potentially contaminated and contaminated' operations was greater (p less than 0.01), in favour of cephaloridine. "
|2.||Wound Infection (Wound Infections)
04/01/1977 - "Prophylactic cephaloridine significantly reduced the overall incidence of wound infection (P less than 0-02) and was also effective when the appendix was gangrenous or perforated (P less than 0-01). "
05/01/1976 - "Local measures in the prevention of wound infections: trials with cephaloridine and two methods of haemostasis."
11/01/1979 - "Wound infections developed in 11 of 42 patients who did not receive cephaloridine, but in none of the 41 patients who were given cephaloridine (p less than 0.02). "
08/01/1979 - "Cephaloridine reduced wound infection from 50.0% to 21.4% (P = 0.05) in those patients in whom drainage tubes were inserted. "
08/01/1979 - "In the total patient series cephaloridine reduced wound infection from 38.3% to 15.4% (P less than 0.003). "
10/01/1970 - "The management of chronic destructive pneumonia with cephaloridine."
04/01/1984 - "The endolymphatic use of gentamicin or ceporin once a day in doses of 80 mg or 1 g respectively provided rapid sanation and arresting of the inflammatory foci, lowering of the intoxication level, more rapid promotion of the positive time course of the clinico-roentgenological and laboratory indices and decreasing of the recovery periods by 1.5-2 times in 86 per cent of the patients with pneumonia. "
09/01/1974 - "A prospective evaluation of cephaloridine, cephalothin, and lincomycin was conducted in 85 patients with pneumonia. "
04/01/1984 - "The efficacy of endolymphatic route of gentamicin and ceporin administration was studied in 89 patients with neurosurgical pathological processes complicated by acute pneumonia (80 patients) and meningoencephalitis (9 patients) usually after ineffective antibiotic therapy according to the routine methods. "
04/01/1980 - "Cephaloridin (ceporin of "Pliva", Yugoslavia) was used in the treatment of patients after allotransplantation of the kidney from a cadaver during the early postoperative period with a purpose of prevention (5 patients) and therapy of complications, such as pneumonia (7 patients), sepsis (3 patients), pyelonephritis of the transplanted kidney (4 patients). "
|4.||Urinary Tract Infections (Urinary Tract Infection)
08/01/1988 - "The incidence of cephaloridine resistance (minimum inhibitory concentration, MIC greater than 8 mg L-1) in isolates from urinary tract infections was 45.1% in Glasgow, 22.6% in Dundee and 25.9% in Edinburgh. "
09/09/1972 - "Absence of nephrotoxicity during cephaloridine therapy for urinary-tract infection."
11/10/1968 - "[Correlation of susceptibility of organisms, dosage and clinical effects, observed in dose-response-curve in cephaloridine treatment of drug-resistant urinary tract infections]."
06/01/1968 - "Cephaloridine in urinary tract infections: influence of the duration of treatment of short-term results."
08/01/1967 - "Cephaloridine in refractory urinary tract infections."
|5.||Acute Kidney Injury (Acute Renal Failure)
06/03/1972 - "[Acute renal insufficiency after administration of cephaloridine]."
10/31/1970 - "Reversible encephalopathy and acute renal failure after cephaloridine."
12/21/1973 - "[Acute renal failure following combined cephaloridine-gentamycin therapy (author's transl)]."
11/01/1971 - "Nephrotoxicity and acute renal failure associated with cephalothin and cephaloridine."
01/01/1994 - "We investigated the possible renal protective effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), a selective and potent adenosine A1-receptor antagonist, against cephaloridine (CER)-induced acute renal failure (ARF) in rats. "
|1.||Anti-Bacterial Agents (Antibiotics)
|1.||Hip Replacement Arthroplasty (Total Hip Replacement)
|2.||Prostatectomy (Retropubic Prostatectomy)